Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 11;6(5):e142.
doi: 10.1097/j.pbj.0000000000000142. eCollection 2021 Sep-Oct.

IgA nephropathy in IgG kappa multiple myeloma

Affiliations

IgA nephropathy in IgG kappa multiple myeloma

Maria Eduarda Couto et al. Porto Biomed J. .

Abstract

Multiple myeloma (MM) frequently affects kidney function through multiple mechanisms. Nonetheless, some patients develop kidney injury due to other causes. A 54-year-old woman was diagnosed with IgG kappa MM developed IgA nephropathy without cast nephropathy. Further studies did not show criteria for MM progression or other causes. This case highlights the need for further investigation of kidney injury in MM patients (such as toxicity of previous drugs, infectious events, or immune-mediated disorders).

Keywords: IgA nephropathy; acute kidney injury; corticosteroids; multiple myeloma; purpura.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Light microscopy (hematoxylin & eosin, staining ×20) of the renal biopsy: glomeruli show mesangial hypercellularity, there is a cellular cast within a tubule () and significant polymorphonuclear-predominant interstitial infiltrate.
Figure 2
Figure 2
Immunofluorescence image of the kidney biopsy: IgA ++ in the mesangium. Crystals were not found in the cytoplasm of proximal tube cells, however, light-chain proximal tubulopathy cannot be excluded.

References

    1. Leung N, Nasr SH. Myeloma-related kidney disease. Adv Chronic Kidney Dis. 2014;21:36–47. - PubMed
    1. Heher EC, Rennke HG, Laubach JP, Richardson PG. Kidney disease and multiple myeloma. Clin J Am Soc Nephrol. 2013;8:2007–2017. - PMC - PubMed
    1. Batko J, Malyszko J, Jurczyszyn A, et al. The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance. Nephrol Dial Transplant. 2019;34:1440–1452. - PubMed
    1. McLeish KR, Gohara AF, Gillespie C. Mesangial proliferative glomerulonephritis associated with multiple myeloma. Am J Med Sci. 1985;290:114–117. - PubMed
    1. Floege J, Feehally J. The mucosa-kidney axis in IgA nephropathy. Nat Rev Nephrol. 2016;12:147–156. - PubMed